Catalent | CTLT - Debitur Perdagangan



Debitur Perdagangan Perubahan Tanggal
Agilent USD 1.52B 34M 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Bruker USD 544.9M 6M 2025-12
Centene USD 18.1B 5B 2025-12
Charles River Laboratories USD 1.43B 54.59M 2025-12
Cigna USD 31.71B 3.74B 2025-09
Danaher USD 3.91B 762M 2025-12
Dentsply International USD 688M 34M 2025-12
Elevance Health USD 21.54B 807M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Glaxosmithkline GBP 11.16B 3.46B 2025-09
Hologic USD 584.2M 16.6M 2025-12
Humana USD 3.27B 586M 2025-12
Illumina USD 854M 125M 2025-12
Intuitive Surgical USD 1.53B 267.6M 2025-12
IQVIA Holdings USD 3.43B 113M 2025-12
J&J USD 17.61B 235M 2025-09
Laboratory Of America USD 2.26B 4.5M 2025-12
Lonza CHF 1.78B 55M 2025-12
McKesson USD 28.21B 73M 2025-12
Merck EUR 4.44B 293M 2025-12
Merck USD 12.12B 596M 2025-09
Mettler Toledo International USD 778.24M 90.98M 2025-12
Novartis USD 8.98B 192M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
Quest Diagnostics USD 1.41B 48M 2025-12
Repligen USD 158.59M 9.62M 2025-12
Revvity USD 744.67M 64.41M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Thermo Fisher Scientific USD 8.9B 11M 2025-12
UnitedHealth USD 23.02B 346M 2025-12
Veradigm USD 234.48M 18.71M 2022-09
Waters USD 828.84M 80.32M 2025-12
West Pharmaceutical Services USD 574.4M 50.6M 2025-12